IP Library Granted Patent US 7,999,051
Granted Patent B2
US 7,999,051 · App. 12/594,618 · Granted Aug 16, 2011

Furanone copolymers

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,999,051
App. No.
12/594,618
Granted
Aug 16, 2011
Kind
B2
Abstract

The present disclosure provides copolymers including a first monomer including at least one phospholipid possessing at least one vinyl group and a second monomer including a furanone possessing vinyl and/or acrylate groups. Compositions, medical devices, and coatings including such copolymers are also provided.

Claims (38)

1. A copolymer comprising:

a first monomer comprising at least one vinyl phospholipid monomer; and

a second monomer of formula:

wherein R 2 , R 3 and R 4 are independently or all H or halogen; and

R 1 is a moiety selected from the group consisting of H, halogen, formyl, carboxyl, cyano, ester, amide, alkyl, alkoxy, oxoalkyl, alkenyl, alkynyl, aryl or arylalkyl,

wherein at least one of R 1 , R 2 , R 3 and R 4 are substituted with a moiety selected from the group consisting of vinyl moieties and acrylate moieties.

2. The copolymer of claim 1 , wherein the first monomer comprises a phosphorylcholine possessing at least one vinyl group of the formula:

wherein x is from about 1 to about 10, and y is from about 1 to about 10.

3. The copolymer of claim 1 , wherein the first monomer is selected from the group consisting of 2-methacryloyloxyethyl phosphorylcholine, 2-acryloyloxyethyl phosphorylcholine and combinations thereof.

4. The copolymer of claim 1 , wherein the second monomer comprises a vinyl furanone.

5. The copolymer of claim 1 , wherein the copolymer possesses a molar ratio of first monomer to second monomer of from about 1:10 to about 10:1.

6. The copolymer of claim 1 , further comprising at least one additional monomer selected from the group consisting of vinyl monomers, acrylate monomers, and combinations thereof.

7. The copolymer of claim 1 , further comprising at least one additional monomer selected from the group consisting of vinyl functional quaternary amines, hydroxyethyl methacrylate, n-vinyl pyrrolidone, sodium acrylate, bis-acrylate, styrene sulfonic acid, butyl acrylate, sulfopropyl acrylate, sulfopropyl methacylate, acrylamide, diacrylamide, methacrylic acid, acrylic acid, polyethylene glycol acrylates, polyethylene glycol/polypropylene glycol acrylates, silicone acrylates, and combinations thereof.

8. A copolymer comprising:

a first monomer comprising a phosphorylcholine possessing at least one vinyl group of the formula:

wherein x is from about 1 to about 10 and y is from about 1 to about 10, and a furanone monomer of formula:

wherein R 2 , R 3 and R 4 are independently or all H or halogen; and

R 1 is a moiety selected from the group consisting of H, halogen, formyl, carboxyl, cyano, ester, amide, alkyl, alkoxy, oxoalkyl, alkenyl, alkynyl, aryl or arylalkyl,

wherein at least one of R 1 , R 2 , R 3 and R 4 are substituted with a moiety selected from the group consisting of vinyl moieties and acrylate moieties.

9. The copolymer of claim 8 , wherein the first monomer is selected from the group consisting of 2-methacryloyloxyethyl phosphorylcholine, 2-acryloyloxyethyl phosphorylcholine and combinations thereof.

10. The copolymer of claim 8 , wherein the second monomer comprises a vinyl furanone.

11. The copolymer of claim 8 wherein the molar ratio of phosphorylcholine to furanone is from about 1:10 to about 10:1.

12. The copolymer of claim 8 , further comprising at least one additional monomer selected from the group consisting of vinyl monomers, acrylate monomers, and combinations thereof.

13. The copolymer of claim 8 , further comprising at least one additional monomer selected from the group consisting of vinyl functional quaternary amines, hydroxyethyl methacrylate, n-vinyl pyrrolidone, sodium acrylate, bis-acrylate, styrene sulfonic acid, butyl acrylate, sulfopropyl acrylate, sulfopropyl methacylate, acrylamide, diacrylamide, methacrylic acid, acrylic acid, polyethylene glycol acrylates, polyethylene glycol/polypropylene glycol acrylates, silicone acrylates, and combinations thereof.

14. An article comprising:

a first monomer comprising at least one vinyl phospholipid monomer; and

a second monomer of formula:

wherein R 2 , R 3 and R 4 are independently or all H or halogen; and

R 1 is a moiety selected from the group consisting of H, halogen, formyl, carboxyl, cyano, ester, amide, alkyl, alkoxy, oxoalkyl, alkenyl, alkynyl, aryl or arylalkyl,

wherein at least one of R 1 , R 2 , R 3 and R 4 are substituted with a moiety selected from the group consisting of vinyl moieties and acrylate moieties.

15. The article of claim 14 , wherein the first monomer comprises a phosphorylcholine possessing at least one vinyl group of the formula:

wherein x is from about 1 to about 10, and y is from about 1 to about 10.

16. The article of claim 14 , wherein the first monomer is selected from the group consisting of 2-methacryloyloxyethyl phosphorylcholine, 2-acryloyloxyethyl phosphorylcholine and combinations thereof.

17. The article of claim 14 , wherein the second monomer comprises a vinyl furanone.

18. The article of claim 14 , wherein the article possesses from about 2 to about 8 moles of the second monomer per mole of the first monomer.

19. The article of claim 14 , wherein the article is selected from the group consisting of sutures, surgical meshes, contact lenses, intraocular lenses, staples, clips, buttresses, lapbands, catheters, bandages, stents, grafts, stent/grafts, knotless wound closures, sealants, adhesives, tissue scaffolds, pins, screws, orthopedic hardware, pacers, and pacemakers.

20. The article of claim 14 , further comprising at least one additional monomer selected from the group consisting of vinyl monomers, acrylate monomers, and combinations thereof.

21. The article of claim 14 , further comprising at least one additional monomer selected from the group consisting of vinyl functional quaternary amines, hydroxyethyl methacrylate, n-vinyl pyrrolidone, sodium acrylate, bis-acrylate, styrene sulfonic acid, butyl acrylate, sulfopropyl acrylate, sulfopropyl methacylate, acrylamide, diacrylamide, methacrylic acid, acrylic acid, polyethylene glycol acrylates, polyethylene glycol/polypropylene glycol acrylates, silicone acrylates, and combinations thereof.

Assignments (2)
CHANGE OF NAME Recorded Oct 2, 2012
From: TYCO HEALTHCARE GROUP LP
To: COVIDIEN LP
Reel/Frame 029065/0448 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 5, 2009
From: STOPEK, JOSHUA B.
To: TYCO HEALTHCARE GROUP LP
Reel/Frame 023324/0020 →